Due to the growing elderly population and increased prevalence of chronic kidney diseases, North America is anticipated to hold a significant market share in the global urinalysis market. Kidney failure is linked to chronic kidney disease. The National Kidney Foundation's 2021 statistics show that chronic kidney disease kills more people than breast and prostate cancer combined. It currently has an impact on about 37 million people. About 15% of the adult population is affected, and older people are more likely to have it. Thus, the need for accurate chronic kidney disease diagnosis and treatment arises, and as a result, these factors are anticipated to increase demand for the urinalysis market.